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3The pregnancy of this 25-year-old G2/P2 had been 
uneventful until 26 0/7 weeks of gestation when the 
mother was admitted to an outside hospital because 
of vaginal bleeding due to placenta praevia. Tocolysis 
with nifedipin was administered and fetal lung matu-
ration was induced.  
At 28 1/7 weeks of gestation, the mother had been 
transferred to the university hospital for further inve-
stigations of ventriculomegaly. Apart from ventricu-
lomegaly (Fig. 1), ultrasound examinations revealed 
dilatation of the third ventricle, periventricular echo-
densities, a hyperechogenic matrix zone (Fig. 2), and 
an elevated peak systolic velocity in the middle cere-
bral artery (Fig. 3). A fetal MR confirmed the sonogra-
phic findings and revealed aqueduct obstruction, he-
morrhages in the basal ganglia and thalamus, as well 
as multiple subcortical cysts (Fig. 4). No calcifications 
were seen. 
At this point, the etiology of these findings remained 
unclear and further tests were initiated in an attempt 
to explain the various findings on MRI: tests for ma-
ternal anti-platelet antibodies (to explain the he-
morrhages) and fetal hemoglobin in maternal blood 
(to explain the elevated peak systolic velocity in the 
MAC)) were negative. TORCH serology was performed 
and was positive for toxoplasmosis IgG and IgM. IgG 
avidity of 0.249 indicated that the infection must have 
occurred at least four months ago. The exact point 
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4of infection could not be determined; however, toxo-
plasmosis sero logy had been negative during the first 
pregnancy in 2011. Although the MRI findings could 
not to be fully explained by the diagnosis, congenital 
toxoplasmosis was highly suspected. Ventriculomegaly 
as well as the periventricular echodensities with cyst 
formation were progressive in the following weeks of 
the pregnancy; the Doppler abnormalities persisted 
and mild ascites was diagnosed at 30 3/7 weeks of 
gestation. One week later, at 31 4/7 weeks of gesta-
tion, a Cesarean section was performed because of 
progressive vaginal bleeding from a placenta praevia. 
The Apgar scores were 1, 3, 3 at 1, 5 and 10 minutes, 
respectively. Arterial cord-pH was 7.20. Because of 
bradycardia and apnea bag and mask ventilation was 
started with a maximal FiO2 of 1.0. Intubation was 
difficult because of hydrops and succeeded not until 
the age of 20 minutes. Afterwards the FiO2 could be 
reduced to 0.3 and the baby was transported to the 
neonatal intensive care unit. 
The baby had a birth weight of 2130g (P75-90), a 
length of 41cm (P25-50) and a head circumference 
of 36.5cm (P>97). Physical examination on admissi-
on showed a severely ill child without any spontane-
ous movements, generalized edema of the skin most 
distinct on head and trunk, bilateral pulmonary rales, 
a 2/6 systolic heart murmur with normal blood pressu-
5Fetal ultrasound examination at 28 1/7 weeks of ge-
station: severe ventriculomegaly.
Fig. 1
6re and palpable pulses, hepatosplenomegaly, bilateral 
cryptorchidism and disseminated petechiae.
Laboratory investigations revealed mixed acidosis (pH 
7.04, a pCO2 9.4 kPa, and a BE -11.7 mmol/l), anemia 
(hematocrit 23%) and erythroblastosis (82/100 WBC), 
a WBC of 18.8 G/l, thrombocytopenia (31 G/l) and pa-
thological coagulation parameters (Quick 38%, INR 
1.3, aPPT 74 s, TT 45 s, fibrinogen 1.2 g/l). 
Fetal ultrasound examination at 28 1/7 weeks of gesta-
tion: dilatation of the third ventricle, periventricular 
echodensities and hyperechogenic matrix zone. 
Fig. 2
7A babygram showed bilateral pleural effusions and 
cardiomegaly (Fig. 5). Echocardiography revealed en-
larged ventricles with normal contractility, signs of 
pulmonary hypertension, dilatation of the inferior 
vena cava, and no pericardial effusions. The prenatal 
imaging findings were confirmed by cerebral ultra-
sound: severe hydrocephalus with only a narrow rim of 
parenchyma with increased echogenicity and multiple 
cysts. No normal gyri and sulci could be demonstrated. 
The basal ganglia were small with increased echoge-
nicity (Fig. 6).
In view of the critical clinical condition and extremely 
poor neurological prognosis, a decision was made to 
redirect care to comfort measures. After extubation, 
the infant died at the age of 5 hours. 
The symptoms described above were suggestive of a 
prenatal infection. Based on maternal serology, con-
genital toxoplasmosis was most likely. This diagno-
sis was confirmed by histopathology of the placenta 
and detection of toxoplasmosis DNA in umbilical cord 
blood. At the request of the parents, no autopsy was 
performed. 
8Fetal color Doppler study: elevated peak systolic velo-
city in the middle cerebral artery. 
Fig. 3
9Fetal MRI: hemorrhages in the basal ganglia (ar-
rowheads) and thalamus and multiple subcortical 
cysts (arrows).
Fig. 4
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Babygram: hydrops with bilateral pleural effusions 
and cardiomegaly. 
Fig. 3
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Fig. 6
Postnatal cerebral ultrasound examination: pro-
nounced hydrocephalus on coronal (A, B) and sagittal 
views (C); increased periventricular echogenicity and 
cysts.
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DISCuSSION Toxoplasma gondii is a ubiquitous protozoan parasite. 
Infection can be acquired from contaminated soil or by 
consumption of undercooked meat or unpasteurized 
milk. Acute infection with T. gondii is usually asym-
ptomatic in children and adults, but serious clinical di-
sease can result from congenital infection (1). Clinical 
manifestations largely depend on when the infection 
is acquired in utero. Vertical transmission rate is lower 
in early pregnancy than in later pregnancy but results 
in more severe clinical disease (2). Clinical manifesta-
tion of congenital toxoplasmosis includes chorioreti-
nitis, anemia, jaundice, petechiae due to thrombocy-
topenia, pneumonitis, hepatosplenomegaly, diarrhea 
and neurological manifestations such as microcephaly, 
intracranial calcifications, epilepsy, encephalitis and 
hydrocephalus, resulting in various degrees of psycho-
motor and/or mental retardation (1, 2).
Ventriculomegaly and multiple intracranial calcifica-
tions (periventricular regions, basal ganglia, and cor-
ticomedullary junction) are typical findings on cere-
bral ultrasound.  Further characteristic signs, although 
less well known, include multiple echogenic nodular 
foci located in the brain parenchyma, periventricular 
or caudothalamic zones, diffuse periventricular echo-
genicity and periventricular cysts (3). In severe cases, 
cerebral toxoplasmosis may produce brain abscesses 
with cyst formation resembling posthemorrhagic in-
sults (3). Cerebral ultrasound and MRI findings in our 
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patient are therefore consistent with congenital toxo-
plasmosis.
The prognosis of children with congenital toxoplasmo-
sis, not surprisingly, correlates with the extent of brain 
involvement. Ventriculomegaly associated with multi-
ple echodense nodules, as in our case, is characteri-
stic of severe congenital toxoplasmosis and carries a 
poor prognosis (3). In contrast, children with normal 
ventricular size and only a few brain nodules can have 
normal neurological development. 
Until 2009, screening for toxoplasmosis during preg-
nancy was performed in Switzerland, even though no 
official recommendation existed (4). In 2009, the Swiss 
Working Group on congenital Toxoplasmosis (SWGT) 
recommended the cessation of testing for T. gondii 
antibodies before and during pregnancy (5). The main 
arguments for this new strategy where the low inci-
dence and morbidity of congenital toxoplasmosis in 
Switzerland (only 1 case of congenital toxoplasmosis 
per 2300 live births, and only 1 symptomatic infection 
per 14‘000 live births) (5) and above all, the fact that 
there is no evidence at all that screening and therapy 
during pregnancy is effective. A broad review of all 
available data (EUROTOXO Study) could not provide 
any scientific proof that maternal treatment during 
pregnancy would translate into any beneficial effects 
for the fetus (6, 7). Instead, the SWGT emphasized the 
importance of primary prophylaxis, the only preventi-
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on strategy which showed some effect in the EURO-
TOXO Study (6, 7).
In our case, maternal serologies indicated that the in-
fection must have taken place in the first trimester 
of pregnancy with severe fetal consequences. At the 
time of diagnosis, extensive cerebral injury had already 
occurred. Based on the evidence from the literature, 
it is highly doubtful, if earlier diagnosis and therapy 
would have altered the fate of the child (3, 5-8). Since 
the mother had a migration background and did not 
speak any German or another European language, it is 
likely that she was not informed about risk factors and 
primary prevention of toxoplasmosis (9).
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